Am J Transplant, Volume 22, Suppl 3 Archives - Page 180 of 190 - ATC Abstracts

2022 American Transplant Congress
Donor Hospital Referrals of Potential Deceased Donors Slow Down on Weekends
A. L. Friedman, E. Marquez, H. Ghali
LiveOnNY, Long Island City, NY
*Purpose: As a condition of participation, CMS requires the referral to an organ procurement organization (OPO) of patients with death or imminent death by every…
2022 American Transplant Congress
Smartphone-Microfluidic Fluorescence Imaging System for Studying Islet Physiology
X. Yu, Y. Xing, Y. Zhang, P. Zhang, Y. He, M. K. Ramasubramanian, Y. Wang, H. Ai, J. Oberholzer
University of Virginia, Charlottesville, VA
*Purpose: The goal of this study is to develop an innovative smartphone-microfluidic fluorescence imaging (µSFI) system for multi-parameter islet function characterization, which could provide quantitative…
2022 American Transplant Congress
Circumstances Influencing Likelihood to Become an Organ Donor
L. Clayton¹, K. S. Holland², C. W. Nonterah³
¹Psychology, Department of Psychology, University of Richmond, Richmond, VA, ²Psychology, Department of Psychiatry, Virginia Commonwealth University, School of Medicine, Richmond, VA, ³Department of Psychology, University of Richmond and Department of Psychiatry, Virginia Commonwealth University, School of Medicine, Richmond, VA
*Purpose: Currently, there are approximately 102,000 patients on the waitlist for a renal or liver transplant (Organ Procurement and Transplantation Network (OPTN), 2021). In 2021,…
2022 American Transplant Congress
Outcomes of a Novel Belatacept-Based Regimen – Beyond 2 Years of Follow-Up
G. Katz-Greenberg¹, J. Byrns²
¹Department of Medicine, Duke University Medical Center, Durham, NC, ²Department of Pharmacy, Duke University Medical Center, Durham, NC
*Purpose: For kidney transplant recipients (KTR) there are limited choices of immunosuppression (IS) maintenance regimens. The most commonly used regimen consists of a calcineurin inhibitor…
2022 American Transplant Congress
Validation of Trugraf Gene Expression Profile in a Multicenter Cohort (TOGETHER Study)
M. Mai¹, W. Park², R. Heilman³, B. Smith², R. First⁴, J. Fleming⁴, P. West-Thielke⁴, J. Holman⁴, M. Stegall²
¹Mayo Clinic Jacksonville, Jacksonville, FL, ²Mayo, Rochester, MN, ³Mayo, Phoenix, AZ, ⁴Transplant Genomics, Framingham, MA
*Purpose: The purpose of this study was to validate the performance characteristics of TruGraf GEP in a real-world population.*Methods: This was a multicenter observational analysis…
2022 American Transplant Congress
Variation in Definition of Death in Donation After Circulatory Death Policies
D. Cassidy¹, M. J. Englesbe², V. S. Valbuena²
¹University of Michigan Medical School, Ann Arbor, MI, ²Department of Surgery, University of Michigan, Ann Arbor, MI
*Purpose: Organ transplantation operates through a shared network requiring organizations, hospitals, and individuals to work towards a common goal. However, the policies that govern each…
2022 American Transplant Congress
Interaction Between Financial Barriers and Other Motivators, Barriers, and Facilitators of Living Organ Donation
A. R. Smith¹, R. J. Mandell¹, M. E. Helmuth¹, N. P. Goodrich¹, J. B. Wiseman¹, K. A. Gifford², M. A. Fava¹, A. O. Ojo³, R. M. Merion¹, A. K. Mathur⁴
¹Arbor Research Collaborative for Health, Ann Arbor, MI, ²American Society for Transplant Surgeons, Arlington, VA, ³University of Kansas Medical Center, Kansas City, KS, ⁴Mayo Clinic, Phoenix, AZ
*Purpose: Our objective was to assess how financial barriers to living donation interact with other motivators, barriers, and facilitators during the decision-making process.*Methods: Data were…
2022 American Transplant Congress
Effect of Micafungin Bridging on Prevention of Invasive Candidiasis Post Lung Transplantation
C. Baladad¹, M. Converse¹, K. DeSear¹, S. Karimi¹, E. Rubido¹, G. El Helou², T. Pasley¹
¹Pharmacy, University of Florida Health, Shands, Gainesville, FL, ²Infectious Diseases, University of Florida Health, Shands, Gainesville, FL
*Purpose: This study aims to determine the effect of micafungin, added as a bridging agent to azole antifungal prophylaxis, in lung transplantation patients with positive…
2022 American Transplant Congress
Use of De Novo mTOR Inhibitors in Highly Sensitized Kidney Transplant Recipients
J. Bastos¹, T. Freesz², C. Bisi³, C. Marinho², A. Pires², V. Colares³, R. Neto², G. Ferreira²
¹Tranplant Unit, Santa Casa De Misericordia De Juiz de Fora, Juiz de Fora, Brazil, ²Transplant Unit, Santa Casa De Misericórdia De Juiz de Fora, Juiz de Fora, Brazil, ³Tranplant Unit, Santa Casa De Misericórdia De Juiz de Fora, Juiz de Fora, Brazil
*Purpose: mTOR inhibitors (mTORi) allow calcineurin-inhibitor reduction without loss of efficacy and may improve allograft-transplant outcomes. However, the safety of this protocol in high-immunological risk…
2022 American Transplant Congress
Developing A Tool To Assess Psychosocial Determinants Of Health And Quality Of Life In Pediatric Liver Transplant Patients
C. R. Christmann¹, S. Rath², S. Sakhuja³, N. Galvan²
¹Baylor College of Medicine, Houston, TX, ²Baylor College of Medicine, Houston, TX, ³Baylor College of Medicine, Sugar Land, TX
*Purpose: Psychosocial assessment prior to liver transplantation is essential to ensure that caregivers and pediatric patients are adequately prepared for this complex process. There are…